The Fort Worth Press - Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

USD -
AED 3.673042
AFN 65.503991
ALL 82.870557
AMD 381.503986
ANG 1.790055
AOA 917.000367
ARS 1434.006204
AUD 1.505729
AWG 1.8
AZN 1.70397
BAM 1.678705
BBD 2.013364
BDT 122.282772
BGN 1.680385
BHD 0.37694
BIF 2967
BMD 1
BND 1.294944
BOB 6.907739
BRL 5.418041
BSD 0.999601
BTN 89.876145
BWP 13.280747
BYN 2.873917
BYR 19600
BZD 2.010437
CAD 1.383405
CDF 2232.000362
CHF 0.804604
CLF 0.023471
CLP 920.770396
CNY 7.070104
CNH 7.06959
COP 3817.5
CRC 488.298936
CUC 1
CUP 26.5
CVE 95.103894
CZK 20.77405
DJF 177.720393
DKK 6.412285
DOP 64.250393
DZD 129.962727
EGP 47.569904
ERN 15
ETB 155.051714
EUR 0.858404
FJD 2.25845
FKP 0.748861
GBP 0.74968
GEL 2.703861
GGP 0.748861
GHS 11.45039
GIP 0.748861
GMD 73.000355
GNF 8687.503848
GTQ 7.657084
GYD 209.137648
HKD 7.78484
HNL 26.328145
HRK 6.471904
HTG 130.859652
HUF 328.06704
IDR 16691.4
ILS 3.23571
IMP 0.748861
INR 89.97675
IQD 1309.540669
IRR 42112.503816
ISK 127.920386
JEP 0.748861
JMD 159.999657
JOD 0.70904
JPY 155.243504
KES 129.303801
KGS 87.450384
KHR 4005.00035
KMF 422.00035
KPW 899.993191
KRW 1472.865039
KWD 0.30668
KYD 0.833083
KZT 505.531856
LAK 21676.809119
LBP 89516.767233
LKR 308.334728
LRD 175.938682
LSL 16.941802
LTL 2.95274
LVL 0.60489
LYD 5.434032
MAD 9.231238
MDL 17.00842
MGA 4458.959547
MKD 52.906919
MMK 2099.939583
MNT 3546.502114
MOP 8.016033
MRU 39.863012
MUR 46.070378
MVR 15.410378
MWK 1733.372244
MXN 18.178775
MYR 4.111039
MZN 63.903729
NAD 16.941802
NGN 1450.110377
NIO 36.787647
NOK 10.102304
NPR 143.802277
NZD 1.730805
OMR 0.384505
PAB 0.999682
PEN 3.360156
PGK 4.24115
PHP 58.978038
PKR 280.247111
PLN 3.633604
PYG 6875.152888
QAR 3.643659
RON 4.372204
RSD 100.804038
RUB 76.499736
RWF 1454.419048
SAR 3.753201
SBD 8.223823
SCR 13.497312
SDG 601.503676
SEK 9.403825
SGD 1.295485
SHP 0.750259
SLE 23.000338
SLL 20969.498139
SOS 570.266164
SRD 38.629038
STD 20697.981008
STN 21.02887
SVC 8.745763
SYP 11058.244165
SZL 16.928669
THB 31.871038
TJS 9.171638
TMT 3.5
TND 2.932369
TOP 2.40776
TRY 42.504604
TTD 6.776446
TWD 31.274038
TZS 2435.000335
UAH 41.959408
UGX 3536.283383
UYU 39.096531
UZS 11958.989413
VES 248.585904
VND 26360
VUV 122.070109
WST 2.790151
XAF 563.019389
XAG 0.017039
XAU 0.000237
XCD 2.70255
XCG 1.801608
XDR 0.70002
XOF 562.932418
XPF 102.347136
YER 238.403589
ZAR 16.92915
ZMK 9001.203584
ZMW 23.111058
ZWL 321.999592
  • CMSC

    -0.0800

    23.4

    -0.34%

  • BCC

    -0.5050

    73.755

    -0.68%

  • SCS

    -0.0400

    16.19

    -0.25%

  • BCE

    0.2800

    23.5

    +1.19%

  • GSK

    -0.3250

    48.245

    -0.67%

  • RBGPF

    0.0000

    78.35

    0%

  • RIO

    -0.6400

    73.09

    -0.88%

  • CMSD

    -0.0750

    23.245

    -0.32%

  • NGG

    -0.4300

    75.48

    -0.57%

  • JRI

    0.0050

    13.755

    +0.04%

  • RYCEF

    -0.1400

    14.51

    -0.96%

  • BTI

    -0.8250

    57.215

    -1.44%

  • VOD

    -0.1590

    12.474

    -1.27%

  • RELX

    -0.1200

    40.42

    -0.3%

  • AZN

    0.2200

    90.25

    +0.24%

  • BP

    -1.0750

    36.155

    -2.97%

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence
Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management.

Text size:

ATLANTA, GA / ACCESS Newswire / October 23, 2025 / Florence Healthcare reinforced its position as the global leader in clinical trial operations with a major milestone: Florence Trial Operations Platform now connects 65,000 study sites spanning more than 600 sponsors across 90+ countries, forming the industry's largest network. Recognized as the #1 clinical trial technology for six consecutive years, Florence continues to set the standard for startup speed, workflow automation, and operational risk management across sponsor study portfolios.

"Florence was built to bring sponsors and sites into a shared operational space," said Ryan Jones, CEO of Florence Healthcare. "First, we fully digitized startup to eliminate manual bottlenecks and paper workflows. Now, we're using AI to enhance speed and augment intelligence across 65,000 study sites globally - arming sponsors with portfolio-wide operational visibility so they can anticipate trial risk, act on insights, and drive execution on the ground."

Solving the $1 million per study problem

While digital-first sites set new standards for operational speed and efficiency, much of the industry still remains offline. Only 30% of global sites currently use an eISF, leaving roughly 200,000 sites dependent on inefficient paper processes for study startup, document collection and storage, regulatory process management, monitoring and closeout.

This lack of digitization costs sponsors an estimated $1 million per study in lost productivity, rework, quality and compliance risk.

Florence is closing this digital divide through the fastest growing clinical research network of 65,000 study sites and 600+ sponsors. By digitizing 100% of operational workflows, Florence sets the standard for startup speed, operational cost reduction, and risk control.

The results are compelling:

  • Up to 70% faster last mile study startup operations compared to the average site startup time for a Top 10 global pharmaceutical sponsor.

  • $141M annual operational cost takeout by automating site readiness workflows, based on active daily users and total hours saved per year across Florence's study site network.

  • 51% increase in eTMF QA pass rates from 65% to 98.7%, due to built-in operational audits and automated compliance checks to control risk.

Shaping the Future of Study Operations

Florence is embedding AI across the study lifecycle to unlock operational data intelligence, recommend next-best actions, strengthen risk control, and improve operating efficiency.

Site Identification & Feasibility

Drawing on the industry's largest network of site intelligence, Florence enables sponsors and CROs to identify the most qualified sites by therapeutic area, geography, and performance, while AI-assisted feasibility surveys ensure faster, more accurate completion.

Study Startup

AI-enabled contracting and document exchange between eTMF and eISF automates SSU document exchange, while generative AI redlining shortens contract review cycles, compares terms in seconds, and dramatically reduces time to activation.

Remote Monitoring

AI-powered reporting surfaces early risk signals from operational audit trails and site data, providing real-time visibility and enabling proactive intervention. These insights minimize the need for on-site visits and ensure trials stay on schedule.

Together, these advancements move sponsors and CROs from manual oversight to intelligent execution across global study portfolios. Through its open API network, Florence rapidly integrates and extends its trial operation capabilities to other eClinical partner systems.

Florence AI operates at the speed of trust, ensuring every study remains fully aligned with FDA, EMA, HIPAA, GDPR, EU Annex 11, ICH E6 (R3), and GCP standards.

All capabilities will be available in December 2025.

Join the Movement: Research Revolution 2025

Florence will showcase its newest capabilities at Research Revolution 2025, the company's annual global event (October 26-28, 2025) bringing together sponsors, CROs, and research sites. Be part of the global revolution. Watch it live at: https://researchrevolutionsummit.com/live/

About Florence Healthcare

Florence is a purpose-built platform that connects sponsors and sites to accelerate clinical trials, improve operational capacity, and reduce risk. Designed for scale, Florence streamlines workflows, enhances collaboration, and delivers real-time visibility across studies-empowering research teams to move faster, stay inspection-ready, and increase trial throughput with fewer resources.

Contact Information

Seema Sheth-Voss
[email protected]
(888) 829-0896

SOURCE: Florence Healthcare



View the original press release on ACCESS Newswire

L.Davila--TFWP